Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-090412·Moringa Sponsor, LP
Schedule 13D ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary Shares, par value $0.0135 per share · CUSIP: G1281K130
Event date: 2025-09-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Moringa Sponsor, LPReported CIK 0001849192
Shares: 457,342.00 · Class: 14.63%
- Moringa Partners Ltd
Shares: 458,824.00 · Class: 14.67%
- Ilan Levin
Shares: 458,824.00 · Class: 14.67%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-090412
- Form type
- SCHEDULE 13D/A
- Filer
- Moringa Sponsor, LP
- CIK
- CIK 1849192
- Filed
- Sep 23, 2025
- Reporting period
- Sep 15, 2025
- Description
- Schedule 13D beneficial ownership